B.K.S. Sastry

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

Tomás Pulido, Igor Adzerikho, Richard N. Channick et al. · New England Journal of Medicine · 2013 · 1.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Clinical efficacy of sildenafil in primary pulmonary hypertension

B.K.S. Sastry, C Narasimhan, N. Krishna Reddy et al. · Journal of the American College of Cardiology · 2004 · 490 citations

Medicine, Pharmacology, Pharmacotherapy +12

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension

Robyn J. Barst, D. Dunbar Ivy, Guillermo Gaitan et al. · Circulation · 2011 · 374 citations · Full text

Medicine, Pediatrics, Pharmacology +17

Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality

Vallerie V. McLaughlin, Marius M. Hoeper, Richard N. Channick et al. · Journal of the American College of Cardiology · 2018 · 111 citations · Full text

Medicine, Biostatistics, Cardiology +9

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension

Nazzareno Galiè, Pavel Jansa, Tomás Pulido et al. · European Heart Journal · 2017 · 78 citations · Full text

Medicine, Cardiology, Pharmacology +15